Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypesSchroth, W.; Antoniadou, L.; Fritz, P.; Schwab, M.; Muerdter, T.; Zanger, U.; Simon, W.; Eichelbaum, M.; Brauch, H.
2010CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratificationSchroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.
2008Breast cancer risk reduction and membrane-bound catechol o-methyltransferase genetic polymorphismsJi, Y.; Olson, J.; Zhang, J.; Hildebrandt, M.; Wang, L.; Ingle, J.; Fredericksen, Z.; Sellers, T.; Miller, W.; Dixon, J.; Brauch, H.; Eichelbaum, M.; Justenhoven, C.; Hamann, U.; Ko, Y.; Bruning, T.; Chang-Claude, J.; Wang-Gohrke, S.; Schaid, D.; Weinshilboum, R.
2008A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancerRokavec, M.; Schroth, W.; Amaral, S.; Fritz, P.; Antoniadou, L.; Glavac, D.; Simon, W.; Schwab, M.; Eichelbaum, M.; Brauch, H.
2008Clinical relevance of CYP2D6 genetics for tamoxifen response in breast cancerBrauch, H.; Schroth, W.; Eichelbaum, M.; Schwab, M.; Harbeck, N.
2010Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expressionHennig, G.; Gehrmann, M.; Stropp, U.; Brauch, H.; Fritz, P.; Eichelbaum, M.; Schwab, M.; Schroth, W.
2009Pharmacogenomics of Tamoxifen TherapyBrauch, H.; Murdter, T.; Eichelbaum, M.; Schwab, M.